CompletedPhase 2NCT00006350
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Maryland, Baltimore
- Principal Investigator
- Bijoyesh Mookerjee, MDJefferson Medical College of Thomas Jefferson University
- Intervention
- daclizumab(biological)
- Eligibility
- 18-120 years · All sexes
- Timeline
- 2000 – 2001
Study locations (1)
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00006350 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.